Heterocyclic compounds and their uses as inhibitors of PI3 K activity

Details for Australian Patent Application No. 2010265971 (hide)

Owner Amgen Inc.

Inventors Brown, Matthew; Chen, Yi; Cushing, Timothy D.; Gonzalez Lopez De Turiso, Felix; He, Xiao; Kohn, Todd J.; Lohman, Julia Winslow; Pattaropong, Vatee; Seganish, Jennifer; Shin, Youngsook; Simard, Jillian L.

Agent Shelston IP

Pub. Number AU-A-2010265971

PCT Pub. Number WO2010/151737

Priority 61/220,493 25.06.09 US

Filing date 25 June 2010

Wipo publication date 29 December 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/151737 Priority application(s): WO2010/151737

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010265974-Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases

2010265964-Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy